Aimei Health Technology Co., Ltd. is an innovative leader in the healthcare sector, dedicated to transforming patient care through advanced technology. The company specializes in the development and manufacture of state-of-the-art medical devices and comprehensive health management systems, aimed at improving patient outcomes and optimizing healthcare delivery. With a strong focus on innovation, strategic partnerships, and research-driven initiatives, Aimei is well-positioned to respond to the dynamic needs of the global healthcare landscape, ensuring sustainable growth and delivering impactful solutions in the industry.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -1.04% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.56 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -30.20% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $4.40M |
| % Insiders | 0.00% |
| % Institutions | 0.04% |